Synergistic drug combinations designed to fully suppress SARS-CoV-2 in the lung of COVID-19 patients

por De Forni, Davide, Poddesu, Barbara, Cugia, Giulia, Chafouleas, James, Lisziewicz, Julianna, Lori, Franco
Publicado 2022

VS411 Reduced Immune Activation and HIV-1 RNA Levels in 28 Days: Randomized Proof-of-Concept Study for AntiViral-HyperActivation Limiting Therapeutics

por Lori, Franco, De Forni, Davide, Katabira, Elly, Baev, Denis, Maserati, Renato, Calarota, Sandra A., Cahn, Pedro, Testori, Marco, Rakhmanova, Aza, Stevens, Michael R.
Publicado 2012

SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves

por Manna, Antonio, De Forni, Davide, Bartocci, Marco, Pasculli, Nicola, Poddesu, Barbara, Lista, Florigio, De Santis, Riccardo, Amatore, Donatella, Grilli, Giorgia, Molinari, Filippo, Sangiovanni Vincentelli, Alberto, Lori, Franco
Publicado 2023

Reply to Taylor et al. Comment on “Manna et al. SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves. Viruses 2023, 15, 1443”

por Manna, Antonio, De Forni, Davide, Bartocci, Marco, Pasculli, Nicola, Poddesu, Barbara, Lista, Florigio, De Santis, Riccardo, Amatore, Donatella, Grilli, Giorgia, Molinari, Filippo, Sangiovanni Vincentelli, Alberto, Lori, Franco
Publicado 2023

Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences

por Shepard, Brett D., De Forni, Davide, McNamara, David R., Foli, Andrea, Rizza, Stacey A., Abraham, Roshini S., Knutson, Keith, Wettstein, Peter J., Lori, Franco, Badley, Andrew D.
Publicado 2008